Correlation Between Processa Pharmaceuticals and Rezolute

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Rezolute, you can compare the effects of market volatilities on Processa Pharmaceuticals and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Rezolute.

Diversification Opportunities for Processa Pharmaceuticals and Rezolute

-0.21

Correlation Coefficient

Processa Pharmaceuticals  Rezolute

Very good diversification

The 3 months correlation between Processa and Rezolute is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Rezolute go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Rezolute

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Rezolute. In addition to that, Processa Pharmaceuticals is 2.31 times more volatile than Rezolute. It trades about -0.03 of its total potential returns per unit of risk. Rezolute is currently generating about 0.15 per unit of volatility. If you would invest  88.00  in Rezolute on September 13, 2024 and sell it today you would earn a total of  407.00  from holding Rezolute or generate 462.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Rezolute

Processa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Processa Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Rezolute

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rezolute has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Rezolute is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Processa Pharmaceuticals and Rezolute

The main advantage of trading using opposite Processa Pharmaceuticals and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.

The idea behind Processa Pharmaceuticals and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.